Table 1 Baseline characteristics among incident CVD cases and matched controls

Number

211

633

NA

Age, years

60

60

NA

Male gender, %

66.4

66.4

NA

Smokers, %

31.9

19.6

0.0002

Diabetes %

24.3

15.7

0.005

BMI kg/m2

27.7 ±4.6

26.7 ±3.8

0.0031

Hypertension (>140/90 mm Hg ), %

42.4

25.6

<0.0001

Glucose mmol/L

6.1 ±2.5

5.6 ±1.5

0.0004

Insulin μmol/L

11.4 ±7.1

10.2±6.5

0.0317

Systolic blood pressure, mm Hg

148 ±21.8

139 ±21.2

<0.0001

Diastolic blood pressure, mm Hg

98 ±10.6

85 ± 10.4

<0.0001

Cholesterol, mMol/l

6.1 ±1.0

6.0 ±1.2

0.14

HDL, mMol/l

1.3 ±0.4

1.4 ±0.4

0.0005

LDL, mMol/l

3.9 ±1.2

3.8 ±1.1

0.45

Triglycerides, mMol/l

1.6 ±1.0

1.4 ±0.8

0.0005

hsCRP, mg/l

2.4 (1.3-4.7)

1.7(0.9-3.2)

<.0001

eGFR

90.5 (81.4-106.0)

90.9 (80.4-103.9)

0.73

Framingham Risk Score

14.5±2.3

13.5±2.0

<0.0001

IgM anti-OxCL U/ml, men and women.

88.97(68.36-114.6)

96.90(72.56-123.44)

0.024

IgM anti-OxCL U/ml , men.

84.16(63.38-112.57)

96.90(70.35-123.10)

0.0047

IgM anti-OxCL U/ml , women.

99.06(78.04-123.70)

96.75(74.07-124.37)

0.78

IgM anti-CL U/ml, men and women.

1.87(1.34-3.00)

2.02(1.38-3.12)

0.34